Drugmakers In Us
- All
- News
- Videos
-
Denmark First In European Union To Authorise Merck Covid Pill
Denmark on Thursday recommended US drugmaker Merck's anti-Covid treatment molnupiravir for at-risk patients with symptoms, becoming the first EU country to do so.
-
Pfizer Says "Already Working" On Vaccine Targeting 'Omicron' Variant
Pfizer has already started working on a version of its Covid-19 vaccine specifically targeting the 'Omicron' variant in case the current inoculation is not effective against the new strain, the US drugmaker's CEO Albert Bourla said Monday.
-
US Court Overturns Historic Opioid Ruling Against Drugmaker Johnson & Johnson
The Oklahoma State Supreme Court on Tuesday overturned a historic decision to fine US pharmaceutical giant Johnson & Johnson $465 million for its role in the opioid crisis.
-
Pfizer Seeks US Authorization Of Covid Vaccine For Ages 5-11
US drugmaker Pfizer said Thursday it has formally requested emergency use authorization for its Covid-19 vaccine in children age five to 11.
-
Serum Institute Allowed To Enrol 7-11 Year-Olds In Covid Vaccine Trial
The country's drug regulator today allowed vaccine maker Serum Institute to enrol kids aged 7-11 years for its trial of US drugmaker Novavax's COVID-19 vaccine.
-
AstraZeneca's Antibody Cocktail Fails to Prevent Covid: Study
AstraZeneca Plc's antibody cocktail was only 33% effective at preventing COVID-19 symptoms in people who had been exposed to the virus, failing a study that was key to the drugmaker's pandemic push.
-
Pfizer To Send 50 Million Covid Jabs To India, But With Riders: Report
US pharmaceutical giant Pfizer is likely to supply 50 million COVID-19 vaccines to India in 2021, albeit with a few conditions, sources told ANI on Wednesday. The drugmaker has asked for relaxations in some clauses, sources informed.
-
India, Pfizer Seek To Bridge Dispute Over Vaccine Indemnity: Report
Pfizer and the Indian government are seeking to resolve tensions over a demand by the US drugmaker for legal protection from any claims linked to the use of its COVID-19 vaccine in one of the world's biggest markets, two sources told Reuters.
-
India, Pfizer At Impasse Over Vaccine Indemnity Demand: Report
Pfizer and New Delhi are at loggerheads over a demand by the US drugmaker for legal protection from any claims linked to the use of its COVID-19 vaccine in one of the world's biggest markets, two sources told Reuters.
-
3 Indian Firms To Make, Sell US's Eli Lilly's Baricitinib Drug For Covid Treatment
Eli Lilly and Co said on Monday it had signed licensing agreements with three Indian generic drugmakers to expand the availability of its arthritis drug baricitinib in the country for treating COVID-19 patients.
-
Pfizer Says In Vaccine Supply Talks With India
Pfizer is in discussions with India and committed to make its COVID-19 vaccine available for deployment in the country, the US drugmaker said on Thursday.
-
Indian Drugmaker To Pay $50 Million Fine In US For Irregularities
An Indian drug manufacturer has agreed to plead guilty to concealing and destroying records prior to a 2013 US Food and Drug Administration's inspection of its plant and pay USD 50 million in fines and forfeiture, the Department of Justice has announced.
-
In a First For Southeast Asia, Malaysia Signs Deal With Pfizer for Vaccine
Malaysia has agreed to buy 12.8 million doses of Pfizer's COVID-19 vaccine, becoming the first country in Southeast Asia to announce a deal with the US drugmaker after some expressed reservations over the need for ultra-cold storage.
-
Pfizer To Start COVID-19 Vaccine Pilot Delivery Program In Four US States
Pfizer Inc has launched a pilot delivery program for its experimental COVID-19 vaccine in four U.S. states, as the U.S. drugmaker seeks to address distribution challenges facing its ultra-cold storage requirements.
-
Billion Covid Vaccine Doses Could Be Available By End Of 2021: US Top Health Expert
Drugmakers will likely have tens of millions of doses of coronavirus vaccines in the early part of next year, Anthony Fauci, the top U.S infectious diseases official, said in a Reuters interview on Wednesday, offering a more conservative view of the ramp up than some Trump administration officials.
-
Denmark First In European Union To Authorise Merck Covid Pill
Denmark on Thursday recommended US drugmaker Merck's anti-Covid treatment molnupiravir for at-risk patients with symptoms, becoming the first EU country to do so.
-
Pfizer Says "Already Working" On Vaccine Targeting 'Omicron' Variant
Pfizer has already started working on a version of its Covid-19 vaccine specifically targeting the 'Omicron' variant in case the current inoculation is not effective against the new strain, the US drugmaker's CEO Albert Bourla said Monday.
-
US Court Overturns Historic Opioid Ruling Against Drugmaker Johnson & Johnson
The Oklahoma State Supreme Court on Tuesday overturned a historic decision to fine US pharmaceutical giant Johnson & Johnson $465 million for its role in the opioid crisis.
-
Pfizer Seeks US Authorization Of Covid Vaccine For Ages 5-11
US drugmaker Pfizer said Thursday it has formally requested emergency use authorization for its Covid-19 vaccine in children age five to 11.
-
Serum Institute Allowed To Enrol 7-11 Year-Olds In Covid Vaccine Trial
The country's drug regulator today allowed vaccine maker Serum Institute to enrol kids aged 7-11 years for its trial of US drugmaker Novavax's COVID-19 vaccine.
-
AstraZeneca's Antibody Cocktail Fails to Prevent Covid: Study
AstraZeneca Plc's antibody cocktail was only 33% effective at preventing COVID-19 symptoms in people who had been exposed to the virus, failing a study that was key to the drugmaker's pandemic push.
-
Pfizer To Send 50 Million Covid Jabs To India, But With Riders: Report
US pharmaceutical giant Pfizer is likely to supply 50 million COVID-19 vaccines to India in 2021, albeit with a few conditions, sources told ANI on Wednesday. The drugmaker has asked for relaxations in some clauses, sources informed.
-
India, Pfizer Seek To Bridge Dispute Over Vaccine Indemnity: Report
Pfizer and the Indian government are seeking to resolve tensions over a demand by the US drugmaker for legal protection from any claims linked to the use of its COVID-19 vaccine in one of the world's biggest markets, two sources told Reuters.
-
India, Pfizer At Impasse Over Vaccine Indemnity Demand: Report
Pfizer and New Delhi are at loggerheads over a demand by the US drugmaker for legal protection from any claims linked to the use of its COVID-19 vaccine in one of the world's biggest markets, two sources told Reuters.
-
3 Indian Firms To Make, Sell US's Eli Lilly's Baricitinib Drug For Covid Treatment
Eli Lilly and Co said on Monday it had signed licensing agreements with three Indian generic drugmakers to expand the availability of its arthritis drug baricitinib in the country for treating COVID-19 patients.
-
Pfizer Says In Vaccine Supply Talks With India
Pfizer is in discussions with India and committed to make its COVID-19 vaccine available for deployment in the country, the US drugmaker said on Thursday.
-
Indian Drugmaker To Pay $50 Million Fine In US For Irregularities
An Indian drug manufacturer has agreed to plead guilty to concealing and destroying records prior to a 2013 US Food and Drug Administration's inspection of its plant and pay USD 50 million in fines and forfeiture, the Department of Justice has announced.
-
In a First For Southeast Asia, Malaysia Signs Deal With Pfizer for Vaccine
Malaysia has agreed to buy 12.8 million doses of Pfizer's COVID-19 vaccine, becoming the first country in Southeast Asia to announce a deal with the US drugmaker after some expressed reservations over the need for ultra-cold storage.
-
Pfizer To Start COVID-19 Vaccine Pilot Delivery Program In Four US States
Pfizer Inc has launched a pilot delivery program for its experimental COVID-19 vaccine in four U.S. states, as the U.S. drugmaker seeks to address distribution challenges facing its ultra-cold storage requirements.
-
Billion Covid Vaccine Doses Could Be Available By End Of 2021: US Top Health Expert
Drugmakers will likely have tens of millions of doses of coronavirus vaccines in the early part of next year, Anthony Fauci, the top U.S infectious diseases official, said in a Reuters interview on Wednesday, offering a more conservative view of the ramp up than some Trump administration officials.
